Bhengu et al., 2022 - Google Patents
Immunological interactions between intestinal helminth infections and tuberculosisBhengu et al., 2022
View HTML- Document ID
- 14757880242506581183
- Author
- Bhengu K
- Naidoo P
- Singh R
- Mpaka-Mbatha M
- Nembe N
- Duma Z
- Pillay R
- Mkhize-Kwitshana Z
- Publication year
- Publication venue
- Diagnostics
External Links
Snippet
Helminth infections are among the neglected tropical diseases affecting billions of people globally, predominantly in developing countries. Helminths' effects are augmented by coincident tuberculosis disease, which infects a third of the world's population. The role of …
- 201000001181 parasitic helminthiasis infectious disease 0 title abstract description 74
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/5695—Mycobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Scorza et al. | Cutaneous manifestations of human and murine leishmaniasis | |
Kick et al. | The T-cell response to type 2 porcine reproductive and respiratory syndrome virus (PRRSV) | |
Netland et al. | CD8 and CD4 T cells in west nile virus immunity and pathogenesis | |
Bhengu et al. | Immunological interactions between intestinal helminth infections and tuberculosis | |
Khan et al. | Prophylactic sublingual immunization with Mycobacterium tuberculosis subunit vaccine incorporating the natural killer T cell agonist alpha-galactosylceramide enhances protective immunity to limit pulmonary and extra-pulmonary bacterial burden in mice | |
Matyushenko et al. | Detection of IFNγ-secreting CD4+ and CD8+ memory T cells in COVID-19 convalescents after stimulation of peripheral blood mononuclear cells with live SARS-CoV-2 | |
Solana et al. | Subcutaneous immunization of Leishmania HSP70-II null mutant line reduces the severity of the experimental visceral leishmaniasis in BALB/c mice | |
Hazlewood et al. | A zika vaccine generated using the chimeric insect-specific binjari virus platform protects against fetal brain infection in pregnant mice | |
Bisht et al. | Cystatin from filarial parasites suppress the clinical symptoms and pathology of experimentally induced colitis in mice by inducing T-regulatory cells, B1-cells, and alternatively activated macrophages | |
Ramesh et al. | Parenterally administered P24-VP8* nanoparticle vaccine conferred strong protection against rotavirus diarrhea and virus shedding in gnotobiotic pigs | |
Kamoi et al. | Updates on HTLV-1 uveitis | |
Liang et al. | RHΔ gra17 Δ npt1 strain of Toxoplasma gondii elicits protective immunity against acute, chronic and congenital toxoplasmosis in mice | |
Goatley et al. | Cellular and humoral immune responses after immunisation with low virulent African swine fever virus in the large white inbred Babraham line and outbred domestic pigs | |
Orujyan et al. | Protective efficacy of BCG vaccine against Mycobacterium leprae and non-tuberculous mycobacterial infections | |
Rauf et al. | Humoral and cell-mediated immune response validation in calves after a live attenuated vaccine of Babesia bigemina | |
Wai et al. | Modulating shrimp tropomyosin-mediated allergy: Hypoallergen DNA vaccines induce regulatory T cells to reduce hypersensitivity in mouse model | |
Barroso-Arévalo et al. | The Role of interleukine-10 and interferon-γ as potential markers of the evolution of African swine fever virus infection in wild boar | |
Wang et al. | Vaccination with Aedes aegypti agbr1 delays lethal mosquito-borne Zika virus infection in mice | |
Bortolini et al. | Why physical activity should be considered in clinical trials for COVID-19 vaccines: a focus on risk groups | |
Witschkowski et al. | BCG provides short-term protection from experimental cerebral malaria in mice | |
Zhu et al. | A new role for old friends: effects of helminth infections on vaccine efficacy | |
Owen et al. | A Canadian perspective: monoclonal antibodies for pre-and post-exposure protection from COVID-19 in vulnerable patients with hematological malignancies | |
Bhengu et al. | Cytokine responses during Mycobacterium tuberculosis H37Rv and Ascaris lumbricoides costimulation using human THP-1 and Jurkat cells, and a pilot human tuberculosis and helminth coinfection study | |
Narinyan et al. | Immunologic role of innate lymphoid cells against mycobacterial tuberculosis infection | |
Prapong et al. | Leptospira borgpetersenii leucine-rich repeat proteins provide strong protective efficacy as novel leptospiral vaccine candidates |